Takeda Pharmaceutical
Raghu Shivappa has over 20 years of experience in biopharmaceutical process development, with a strong focus on biologics, gene therapy, and viral vaccines. At Takeda, Raghu served as Vice President and Head of Global Biologics and Gene Therapy Process Development, as well as Senior Director in multiple process development roles. Prior experience includes positions at Johnson & Johnson, where responsibilities spanned large molecule API development and cell culture process development, and Novartis Vaccines and Diagnostics, where leadership included managing teams for upstream process development and overseeing viral vaccine candidates. Raghu's career began at KBI BioPharma and Fujifilm Diosynth Biotechnologies, where management of upstream development teams was key. Educational qualifications include a PhD in Virology and Vaccine Development from the University of Maryland and an MS in Aquaculture Biotechnology from the Asian Institute of Technology.
This person is not in any teams
This person is not in any offices
Takeda Pharmaceutical
177 followers
For more than 230 years, Takeda has brought hope to people around the world through its people-centered and innovation-driven approach to science and medicine. As a global pharmaceutical leader, Takeda focuses on solving unmet needs where it can make a real difference—and on putting patients first. Its therapeutics focus is oncology, gastroenterology, and the central nervous system, as well as vaccines.